50 search results for BDNF
| # | SuperPathway Name | Genes Count | Relevance Score | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BDNF-TrkB signaling | 46 | 1.897 | |||||||
|
||||||||||
| 2 | Downstream signaling of activated FGFR2 | 51 | 1.127 | |||||||
|
||||||||||
| 3 | GDNF-Family Ligands and Receptor Interactions | 100 | 1.127 | |||||||
|
||||||||||
| 4 | IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | 10 | 0.679 | |||||||
|
||||||||||
| 5 | Beta-Adrenergic Signaling | 333 | 0.448 | |||||||
|
||||||||||
| 6 | Neural Stem Cells and Lineage-specific Markers | 79 | 0.448 | |||||||
|
||||||||||
| 7 | CREB Pathway | 529 | 0.448 | |||||||
|
||||||||||
| 8 | Gene expression (Transcription) | 1546 | 0.448 | |||||||
|
||||||||||
| 9 | Cytoskeleton remodeling Regulation of actin cytoskeleton by Rho GTPases | 187 | 0.448 | |||||||
|
||||||||||
| 10 | Akt Signaling | 682 | 0.448 | |||||||
|
||||||||||
| 11 | Signaling by Receptor Tyrosine Kinases | 524 | 0.448 | |||||||
|
||||||||||
| 12 | Transcriptional Regulation by MECP2 | 62 | 0.448 | |||||||
|
||||||||||
| 13 | Opioid receptor pathways | 6 | 0.448 | |||||||
|
||||||||||
| 14 | SHP2 signaling | 54 | 0.448 | |||||||
|
||||||||||
| 15 | PAK Pathway | 686 | 0.448 | |||||||
|
||||||||||
| 16 | MAPK signaling pathway | 244 | 0.448 | |||||||
|
||||||||||
| 17 | Nanog in Mammalian ESC Pluripotency | 534 | 0.448 | |||||||
|
||||||||||
| 18 | Hepatocyte growth factor receptor signaling | 115 | 0.448 | |||||||
|
||||||||||
| 19 | MIF Mediated Glucocorticoid Regulation | 681 | 0.448 | |||||||
|
||||||||||
| 20 | Transcriptional Regulation by NPAS4 | 34 | 0.448 | |||||||
|
||||||||||
| 21 | PI3K-Akt signaling pathway | 390 | 0.448 | |||||||
|
||||||||||
| 22 | ERK Signaling | 1185 | 0.448 | |||||||
|
||||||||||
| 23 | NF-KappaB Family Pathway | 242 | 0.448 | |||||||
|
||||||||||
| 24 | TNF Superfamily - Human Ligand-Receptor Interactions and their Associated Functions | 170 | 0.448 | |||||||
|
||||||||||
| 25 | p70S6K Signaling | 392 | 0.448 | |||||||
|
||||||||||
| 26 | Primary ovarian insufficiency | 170 | 0.448 | |||||||
|
||||||||||
| 27 | Neuroinflammation and glutamatergic signaling | 140 | 0.448 | |||||||
|
||||||||||
| 28 | Fragile X syndrome | 120 | 0.448 | |||||||
|
||||||||||
| 29 | TGF-Beta Pathway | 653 | 0.448 | |||||||
|
||||||||||
| 30 | GPCR Pathway | 712 | 0.448 | |||||||
|
||||||||||
| 31 | mBDNF and proBDNF regulation of GABA neurotransmission | 38 | 0.448 | |||||||
|
||||||||||
| 32 | Signaling by NTRKs | 134 | 0.448 | |||||||
|
||||||||||
| 33 | Posttranslational regulation of adherens junction stability and dissassembly | 48 | 0.448 | |||||||
|
||||||||||
| 34 | Neural crest cell migration in cancer | 34 | 0.448 | |||||||
|
||||||||||
| 35 | Neurogenesis regulation in the olfactory epithelium | 57 | 0.448 | |||||||
|
||||||||||
| 36 | Apoptotic Pathways in Synovial Fibroblasts | 731 | 0.448 | |||||||
|
||||||||||
| 37 | ERK pathway in Huntington's disease | 15 | 0.448 | |||||||
|
||||||||||
| 38 | Neuropathic Pain-Signaling in Dorsal Horn Neurons | 232 | 0.448 | |||||||
|
||||||||||
| 39 | p75(NTR)-mediated signaling | 61 | 0.448 | |||||||
|
||||||||||
| 40 | Phospholipase-C Pathway | 503 | 0.448 | |||||||
|
||||||||||
| 41 | Neurotrophic factor-mediated Trk receptor signaling | 50 | 0.448 | |||||||
|
||||||||||
| 42 | MECP2 and associated Rett syndrome | 73 | 0.448 | |||||||
|
||||||||||
| 43 | Spinal cord injury | 115 | 0.448 | |||||||
|
||||||||||
| 44 | Sudden infant death syndrome (SIDS) susceptibility pathways | 159 | 0.448 | |||||||
|
||||||||||
| 45 | Prader-Willi and Angelman syndrome | 60 | 0.448 | |||||||
|
||||||||||
| 46 | Signal Transduction | 2590 | 0.448 | |||||||
|
||||||||||
| 47 | Malignant pleural mesothelioma | 409 | 0.448 | |||||||
|
||||||||||
| 48 | Guidance Cues and Growth Cone Motility | 117 | 0.448 | |||||||
|
||||||||||
| 49 | Activation of cAMP-Dependent PKA | 632 | 0.448 | |||||||
|
||||||||||
| 50 | G-Beta Gamma Signaling | 219 | 0.448 | |||||||
|
||||||||||